NCT01154621

Assessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female Subjects

A Phase I, Double-blind, Randomized, Placebo-Controlled Study to Assess the Safety and Tolerability, and Pharmacokinetics of a Single Dose of AZD9742 in Healthy Elderly Male and Female Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: AstraZeneca · Industry
• Sex: All
• Age: 65 Years
• Healthy volunteers: Accepted

Summary

The aim of this study is to examine the safety and tolerability of a single dose of AZD9742 in elderly individuals.

Conditions

• Tolerability
• Healthy
• Elderly

Interventions

Type	Name	Description
DRUG	AZD9742	Sterile solution, 620 mg (20 mg/mL) in 50 mL vial with a fill volume of 31 mL
DRUG	Placebo	Sterile 5% dextrose solution

Timeline

• Start date: 2010-06-01
• Primary completion: 2010-07-01
• Completion: 2010-07-01
• First posted: 2010-07-01
• Last updated: 2010-08-03

Locations

1 site across 1 country: United States